Dandanie, Jenna A.

HRN: 25-17-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/22/2024
08/05/2024
IV
4.5
Q8
Infected Breast Mass
Waiting Final Action 
07/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/22/2024
08/05/2024
IV
600
Q8
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: